Establishing a cardiovascular health and wellness program in a community pharmacy: screening for metabolic syndrome

Journal of the American Pharmacists Association : JAPhA
Julie L Olenak, Meghan Calpin

Abstract

To implement a comprehensive service to screen for metabolic syndrome, assess the prevalence of metabolic syndrome, determine the 10-year risk of developing coronary heart disease (CHD), and measure the effectiveness of patient education on lifestyle modifications. Cross-sectional study. Community pharmacy in Pennsylvania between February 2006 and August 2007. 239 patients 18 years of age or older with no history of CHD. Participating patients were screened for metabolic syndrome, Framingham risk assessment, and medication use. Test results were discussed and patients were educated on metabolic syndrome and lifestyle recommendations. A follow-up survey was administered. Prevalence of metabolic syndrome in the study population, Framingham risk assessment of those with metabolic syndrome, proportion of patients with self-reported lifestyle modifications. The prevalence of metabolic syndrome in our study population was 36%. The Framingham risk assessment of patients with metabolic syndrome and no known history of diabetes revealed that 65.3% were at low risk, 26.4% were at moderate risk, and 8.3% were at high risk for CHD. Of the study population with no known history of prediabetes or diabetes, 26% had an abnormal glucose reading...Continue Reading

References

May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Sep 29, 2004·Diabetes Care·Earl S FordAli H Mokdad
Oct 14, 2006·Journal of the American Pharmacists Association : JAPhA·Jennifer L Rodis, Renee Ahrens Thomas
Dec 19, 2007·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Apr 17, 2008·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·John G MastronardeUNKNOWN American Lung Association Asthma Clinical Research Centers
Jan 1, 2003·Journal of the American Pharmaceutical Association : APhA·Lynne Marie Ciardulli, Jean-Venable R Goode

❮ Previous
Next ❯

Citations

Jun 3, 2014·BMC Public Health·Maria Angeles Via-SosaMarian A March
Aug 24, 2013·American Journal of Pharmaceutical Education·Erin C Raney
Oct 17, 2012·International Journal of Clinical Pharmacy·Maram G KatoueSamuel B Kombian
Nov 10, 2011·Journal of the American Pharmacists Association : JAPhA·Leslie A Mooney, Amy M Franks
Nov 10, 2011·Journal of the American Pharmacists Association : JAPhA·Juraporn Pongwecharak, Tarakamon Treeranurat
May 21, 2013·The International Journal of Pharmacy Practice·Abimbola Adebukola AyorindePawana Sharma
Oct 7, 2017·Journal of Pharmacy Practice·Macey E WolfeBarbara Woods
Jul 20, 2010·The International Journal of Pharmacy Practice·Vibhu PaudyalDerek Stewart
Feb 25, 2014·International Journal of Clinical Pharmacy·Carissa A HanesBandana Saini
Jul 2, 2020·International Journal of Clinical Pharmacy·Rana Moustafa Al AdAwiAntonella Pia Tonna
Dec 2, 2020·Journal of the American Pharmacists Association : JAPhA·Bernadette D Asias-Dinh, Kevin W Garey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.